Across TCGA pan-cancer cohorts, RNU6ATAC7P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC7P’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RNU6ATAC7P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6ATAC7P is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD and KIRC are the cancer types where RNU6ATAC7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.640	.038	2	view →
KIRC	Female	All	+0.156	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6ATAC7P RNA expression & survival · all RNU6ATAC7P data types